Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ALZN

Alzamend Neuro (ALZN) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $1.34 +0.0% on the day -42.5% over 12 months 52-week range $0.86 – $2.61

Share price and insider trades

ALZN closeInsider buyInsider sale
0123NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $69 on 2025-10-23 · Lynne Fahey McgrathSold $3,120 on 2026-08-26 · Milton C Ault IIISold $3,832 on 2025-12-23 · Milton C Ault IIISold $7,066 on 2025-12-19 · William B. HorneSold $47,321 on 2025-10-09 · Milton C Ault IIIBought $329,284 on 2026-04-14 · Milton C Ault III
Bought, 12 months$325K
Sold, 12 months$309K
Insiders buying1
Insiders selling3

Alzamend Neuro insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $325K and 3 sold $309K of ALZN stock on the open market.

ALZN insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $946K sold (10 trades)Q4 2025Q1 2026Q2 2026: $329K bought (5 trades)$329KQ2 2026Q3 2026: $3K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$3K1
Q2 2026$329K5—0
Q1 2026—0—0
Q4 2025—0$946K10

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$6.5MBiotechnology
Profit margin0.0%Revenue growth —
Volume vs. 50-day0.2×Last 5 sessions
Insiders' paper profit+$112KOn all tracked purchases +34.0%

Summary

Over the past 12 months, 1 Alzamend Neuro, Inc. insider reported open-market purchases totaling $325K, while 3 insiders reported sales totaling $309K. Among insiders with enough purchase history to measure, Milton C Ault III (Director) has the highest Insider Score at 62. 0 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

ALZN earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Jul 23, 2025 +11.1% None -6.6%S&P +0.9% -16.7%
Dec 12, 2024 -6.6% None -0.8%S&P -0.5% -5.0%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

ALZN stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 31SEC Milton C Ault IIIDirector Buy 108,388116,648 held (+1312%) $1.00 $108K +34.0% 62
Aug 31SEC Milton C Ault IIIDirector Buy 108,388116,648 held (+1312%) $1.00 $108K +34.0% 62
Aug 31SEC Milton C Ault IIIDirector Sell 2,000 $1.56 $3K -14.1% 62
Aug 31SEC Milton C Ault IIIDirector Buy 2,000new position $1.03 $2K +30.1% 62
Aug 31SEC Milton C Ault IIIDirector Buy 2,000new position $1.03 $2K +30.1% 62
Apr 16SEC Milton C Ault IIIDirector Buy 108,388116,648 held (+1312%) $1.00 $108K +34.0% 62
Dec 30SEC Milton C Ault IIIDirector Sell 1,851 $2.07 $4K -35.3% 62
Dec 23SEC William B. HorneDirector Sell 3,333 $2.12 $7K -36.8% 1
Oct 24SEC Lynne Fahey McgrathDirector Sell 3025 held (−55%) $2.29 $69 -41.5% —
Oct 10SEC Milton C Ault IIIDirector Sell 101,39428,657 held (−78%) $2.44 $247K -45.1% 62
Oct 10SEC Milton C Ault IIIDirector Sell 20,3978,260 held (−71%) $2.32 $47K -42.2% 62
Oct 8SEC Milton C Ault IIIDirector Sell 82,03326,227 held (−76%) $2.45 $201K -45.3% 62
Oct 8SEC Milton C Ault IIIDirector Sell 57,37968,848 held (−45%) $2.49 $143K -46.2% 62
Oct 3SEC Milton C Ault IIIDirector Sell 65,9038,260 held (−89%) $2.44 $161K -45.1% 62
Oct 3SEC Milton C Ault IIIDirector Sell 36,77794,849 held (−28%) $2.35 $86K -43.0% 62
Oct 3SEC Milton C Ault IIIDirector Sell 20,68674,163 held (−22%) $2.39 $49K -43.9% 62

Insiders at Alzamend Neuro, Inc.

InsiderBoughtSoldLast filingScore
Milton C Ault IIIDirector $329K $942K Aug 31, 2026 62
William B. HorneDirector — $7K Dec 23, 2025 1
Lynne Fahey McgrathDirector — $69 Oct 24, 2025 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

ALZN stock: common questions

Are Alzamend Neuro, Inc. insiders buying ALZN stock?

In the past 12 months, 1 insiders reported open-market purchases of ALZN worth $325K. The latest was Director Milton C Ault III bought $108K of ALZN at $1.00 — raises the stake by 1312%.

Are Alzamend Neuro, Inc. insiders selling ALZN stock?

3 insiders reported sales worth $309K over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ALZN's 52-week range?

Over the past year ALZN has traded between $0.86 and $2.61. It last closed at $1.34 on Oct 9, 2026.